Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Roden

Showing results (121-130 of 175) with videos related to

Pageof 18
Sort By:
Cancer Immunology, Immunotherapy : CII|October 27, 2020
PD-1 blockade synergizes with intratumoral vaccination of a therapeutic HPV protein vaccine and elicits regression of tumor in a preclinical modelShiwen Peng, Marietta Tan, Yen-Der Li, et al.
Science Advances|August 12, 2021
Protein detection in blood with single-molecule imagingChih-Ping Mao, Shih-Chin Wang, Yu-Pin Su, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Ubiquitin proteasome system stress underlies synergistic killing of ovarian cancer cells by bortezomib and a novel HDAC6 inhibitorMartina Bazzaro, Zhenhua Lin, Antonio Santillan, et al.
Virology|October 9, 2018
Epithelial boost enhances antigen expression by vaccinia virus for the generation of potent CD8+ T cell-mediated antitumor immunity following DNA priming vaccinationJin Qiu, Shiwen Peng, Ying Ma, et al.
Cell & Bioscience|December 25, 2024
Improved efficacy of therapeutic HPV DNA vaccine using intramuscular injection with electroporation compared to conventional needle and needle-free jet injector methodsShiwen Peng, Darrell Fan, Hsin-Fang Tu, et al.
Journal of Virology|June 15, 2022
RG2-VLP: a Vaccine Designed to Broadly Protect against Anogenital and Skin Human Papillomaviruses Causing Human CancerPola Olczak, Ken Matsui, Margaret Wong, et al.
Mbio|January 20, 2021
Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 AntibodyShiwen Peng, Louise Ferrall, Stephanie Gaillard, et al.
Analytical Chemistry|November 16, 2005
Comparative analysis of cellulose preparation techniques for use with 13C, 14C, AND 18O isotopic measurementsJulia B Gaudinski, Todd E Dawson, Sylvie Quideau, et al.
Vaccine|September 19, 2015
Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17-36 epitopesSubhashini Jagu, Balusubramanyam Karanam, Joshua W Wang, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 21, 2021
Next generation polyphosphazene immunoadjuvant: Synthesis, self-assembly and in vivo potency with human papillomavirus VLPs-based vaccineAlexander Marin, Ananda Chowdhury, Sarah M Valencia, et al.
Pageof 18

Showing results (121-130 of 175) with videos related to

Sort By:
Pageof 18
Cancer Immunology, Immunotherapy : CII|October 27, 2020
PD-1 blockade synergizes with intratumoral vaccination of a therapeutic HPV protein vaccine and elicits regression of tumor in a preclinical modelShiwen Peng, Marietta Tan, Yen-Der Li, et al.
Science Advances|August 12, 2021
Protein detection in blood with single-molecule imagingChih-Ping Mao, Shih-Chin Wang, Yu-Pin Su, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Ubiquitin proteasome system stress underlies synergistic killing of ovarian cancer cells by bortezomib and a novel HDAC6 inhibitorMartina Bazzaro, Zhenhua Lin, Antonio Santillan, et al.
Virology|October 9, 2018
Epithelial boost enhances antigen expression by vaccinia virus for the generation of potent CD8+ T cell-mediated antitumor immunity following DNA priming vaccinationJin Qiu, Shiwen Peng, Ying Ma, et al.
Cell & Bioscience|December 25, 2024
Improved efficacy of therapeutic HPV DNA vaccine using intramuscular injection with electroporation compared to conventional needle and needle-free jet injector methodsShiwen Peng, Darrell Fan, Hsin-Fang Tu, et al.
Journal of Virology|June 15, 2022
RG2-VLP: a Vaccine Designed to Broadly Protect against Anogenital and Skin Human Papillomaviruses Causing Human CancerPola Olczak, Ken Matsui, Margaret Wong, et al.
Mbio|January 20, 2021
Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 AntibodyShiwen Peng, Louise Ferrall, Stephanie Gaillard, et al.
Analytical Chemistry|November 16, 2005
Comparative analysis of cellulose preparation techniques for use with 13C, 14C, AND 18O isotopic measurementsJulia B Gaudinski, Todd E Dawson, Sylvie Quideau, et al.
Vaccine|September 19, 2015
Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17-36 epitopesSubhashini Jagu, Balusubramanyam Karanam, Joshua W Wang, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 21, 2021
Next generation polyphosphazene immunoadjuvant: Synthesis, self-assembly and in vivo potency with human papillomavirus VLPs-based vaccineAlexander Marin, Ananda Chowdhury, Sarah M Valencia, et al.
Pageof 18